Pericardial effusion

Results: 31



#Item
11LEARNING RESOURCES  Correct and Preferred Usage Quiz by Laura King, MA, ELS Directions: The following sentences all contain 1 usage error each. Identify the errors and reword the sentences appropriately based on your rea

LEARNING RESOURCES Correct and Preferred Usage Quiz by Laura King, MA, ELS Directions: The following sentences all contain 1 usage error each. Identify the errors and reword the sentences appropriately based on your rea

Add to Reading List

Source URL: www.amamanualofstyle.com

Language: English - Date: 2012-12-05 19:30:03
12REVIEW ARTICLE  Cardiac Manifestations of Acquired Immunodeficiency Syndrome Pairoj Rerkpattanapipat, MD; Nattawut Wongpraparut, MD; Larry E. Jacobs; Morris N. Kotler, MD

REVIEW ARTICLE Cardiac Manifestations of Acquired Immunodeficiency Syndrome Pairoj Rerkpattanapipat, MD; Nattawut Wongpraparut, MD; Larry E. Jacobs; Morris N. Kotler, MD

Add to Reading List

Source URL: archinte.jamanetwork.com

Language: English
131997 Update of the 1982 American College of Rheumatology Revised Criteria for Classification of Systemic Lupus Erythematosus Criterion Definition

1997 Update of the 1982 American College of Rheumatology Revised Criteria for Classification of Systemic Lupus Erythematosus Criterion Definition

Add to Reading List

Source URL: www.rheumatology.org

Language: English
14SERIOUS, POSSIBLY ASSOCIATED AND UNEXPECTED ADVERSE EVENTS REPORTED FOR HUMAN GENE TRANSFER PROTOCOLS REPORTING PERIOD: [removed]/01 RECOMBINANT DNA ADVISORY COMMITTEE MEETING December 2001 Event

SERIOUS, POSSIBLY ASSOCIATED AND UNEXPECTED ADVERSE EVENTS REPORTED FOR HUMAN GENE TRANSFER PROTOCOLS REPORTING PERIOD: [removed]/01 RECOMBINANT DNA ADVISORY COMMITTEE MEETING December 2001 Event

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-10 13:02:15
15The AMPLATZER® Septal Occluder System Summary of Safety and Effectiveness Data Table of Contents 1.  General Information............................................................................................... 1

The AMPLATZER® Septal Occluder System Summary of Safety and Effectiveness Data Table of Contents 1. General Information............................................................................................... 1

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2001-09-07 08:45:44
16Microsoft Word - APR 9--pericardial effusion

Microsoft Word - APR 9--pericardial effusion

Add to Reading List

Source URL: www.vscot.com

Language: English - Date: 2010-08-19 23:53:51
17Appendix A – FDA Categorization of Events – Sponsor Dispute/Comments

Appendix A – FDA Categorization of Events – Sponsor Dispute/Comments

Add to Reading List

Source URL: www.fda.gov

Language: English
18»Erdheim-Chester Disease«

»Erdheim-Chester Disease«

Add to Reading List

Source URL: www.erdheim-chester.org

Language: English - Date: 2012-12-31 10:07:42
19BioSketch  ANNIKA LINDE DVM PhD

BioSketch ANNIKA LINDE DVM PhD

Add to Reading List

Source URL: www.he.k-state.edu

Language: English - Date: 2014-07-01 17:19:23
20

PDF Document

Add to Reading List

Source URL: profiles.nlm.nih.gov

Language: English - Date: 2003-04-25 13:00:20